Antigenic analysis of classical swine fever virus E2 glycoprotein using pig antibodies identifies residues contributing to antigenic variation of the vaccine C-strain and group 2 strains circulating in China
2010

Study of Antigenic Variation in Classical Swine Fever Virus E2 Glycoprotein

publication Evidence: moderate

Author Information

Author(s): Chen Ning, Tong Chao, Li Dejiang, Wan Jing, Yuan Xuemei, Li Xiaoliang, Peng Jinrong, Fang Weihuan

Primary Institution: Institute of Preventive Veterinary Medicine, Zhejiang Provincial Key Laboratory of Preventive Veterinary Medicine, Zhejiang University, Hangzhou, PR China

Hypothesis

How does the genetic diversity of the E2 glycoprotein in classical swine fever virus affect its antigenicity?

Conclusion

The study found significant antigenic differences between the CSFV vaccine C-strain and group 2 strains circulating in China.

Supporting Evidence

  • The E2 glycoproteins of CSFV C-strain and recent subgroup 2.1 field isolates are genetically different.
  • Single amino acid substitutions significantly increased heterologous binding to anti-QZ-07 serum.
  • Antigenic variation was observed among strains of the same subgroup 2.1.

Takeaway

The E2 protein of the classical swine fever virus changes a lot, which makes it harder for vaccines to work against new strains.

Methodology

The study used ELISA-based binding assays and site-directed mutagenesis to analyze the antigenic variation of the E2 glycoprotein.

Limitations

The study primarily focused on specific strains and may not represent all variations in the field.

Digital Object Identifier (DOI)

10.1186/1743-422X-7-378

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication